Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects

This article aimed to provide a comprehensive overview of the recently published articles investigating FAPI and discuss its clinical utility with an emphasis on its application in tumor diagnostics. Numerous radiopharmaceutical FAPIs, including18F- and68Ga-labeled compounds, have been developed, and they offer various advantages and applications. With the progress in the FAPI PET synthesis to enhance accumulation and retention in pathological lesions, future studies are expected to provide valuable data on its therapeutic efficacy.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research